ESMO adaptation of Lines of Systemic Therapy (EnLiST): a consensus framework for standardising the designation of lines of therapy in solid tumours.
Annals of oncology : official journal of the European Society for Medical Oncology. 2026 May; 37(May):608-623. doi: 10.1016/j.annonc.2026.02.008. pii: S0923-7534(26)00064-5.
Base: PUBMEDEndometrial cancer: A Society of Gynecologic Oncology evidence-based review and recommendations: Part I.
Gynecologic oncology. 2026 Jun; 209(Jun):15-25. doi: 10.1016/j.ygyno.2026.04.004. pii: S0090-8258(26)01944-X.
Base: PUBMEDEndometrial cancer: A Society of Gynecologic Oncology evidence-based review and recommendations, part II.
Gynecologic oncology. 2026 Jun; 209(Jun):120-130. doi: 10.1016/j.ygyno.2026.05.006. pii: S0090-8258(26)01980-3.
Base: PUBMEDInternational multisociety Delphi consensus for liver tumour thermal ablation: margin assessment.
The Lancet. Oncology. 2026 May; 27(May):e248-e258. doi: 10.1016/S1470-2045(26)00143-9. pii: S1470-2045(26)00143-9.
Base: PUBMEDInternational multisociety Delphi consensus for liver tumour thermal ablation: procedural and practice standards.
The Lancet. Oncology. 2026 May; 27(May):e259-e270. doi: 10.1016/S1470-2045(26)00114-2. pii: S1470-2045(26)00114-2.
Base: PUBMEDESGO Consensus Statement on endometrial cancer prevention, risk reduction strategies, and management of women with Lynch syndrome.
European journal of cancer (Oxford, England : 1990). 2026 Jun; 240(Jun):116739. doi: 10.1016/j.ejca.2026.116739. pii: S0959-8049(26)00520-4.
Base: PUBMEDStandardizing the Clinical Approach to Cancer Therapy-Related Cardiac Dysfunction: Applying Cardio-Oncology Guidelines as a Practical Tool for Hematology and Oncology Providers.
Cancer medicine. 2026 Apr; 15(Apr):e71682. doi: 10.1002/cam4.71682. pii: e71682.
Base: PUBMEDEffects of exercise interventions on sarcopenia-related outcomes in cancer patients and survivors: an umbrella review of systematic reviews and meta-analyses.
Journal of cancer survivorship : research and practice. 2026 Jun; doi: 10.1007/s11764-026-02066-6. pii: .
Base: PUBMEDAdenoid cystic carcinoma of the breast: a case series of 26 patients.
Breast cancer research and treatment. 2026 Jun; 217(Jun):doi: 10.1007/s10549-026-07996-4. pii: 49.
Base: PUBMEDAssessing the impact of nutritional status at allogeneic stem cell transplantation on clinical outcomes.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2026 Jun; 34(Jun):doi: 10.1007/s00520-026-10874-w. pii: 645.
Base: PUBMEDSecondary causes of diabetes: a crossroad of endocrinology and oncology.
The lancet. Diabetes & endocrinology. 2026 May; 14(May):422-436. doi: 10.1016/S2213-8587(26)00027-6. pii: S2213-8587(26)00027-6.
Base: PUBMEDOvercoming functional and translational challenges of cellular immunotherapies for solid tumors.
Cancer cell. 2026 Apr; 44(Apr):718-742. doi: 10.1016/j.ccell.2026.02.002. pii: S1535-6108(26)00101-7.
Base: PUBMEDThe interplay of clonal hematopoiesis and cancer: Clinical implications in oncology.
Cancer treatment reviews. 2026 Apr; 145(Apr):103109. doi: 10.1016/j.ctrv.2026.103109. pii: S0305-7372(26)00023-X.
Base: PUBMEDNeutrophil extracellular traps: A central player in liver diseases.
Hepatology communications. 2026 Jun; 10(Jun):doi: 10.1097/HC9.0000000000000970. pii: e0970.
Base: PUBMEDCDK4/6 inhibitors plus endocrine therapy versus endocrine monotherapy in hormone receptor-positive, HER2-negative advanced breast cancer: a reconstructed individual patient data meta-analysis of phase 3 randomised controlled trials.
The Lancet. Oncology. 2026 May; 27(May):592-603. doi: 10.1016/S1470-2045(26)00053-7. pii: S1470-2045(26)00053-7.
Base: PUBMEDSafety and antitumour activity of ipatasertib combined with endocrine therapy and a CDK4/6 inhibitor in HR+/HER2- metastatic breast cancer (TAKTIC): a single-centre, open-label, phase 1b trial.
The Lancet. Oncology. 2026 May; 27(May):580-591. doi: 10.1016/S1470-2045(26)00059-8. pii: S1470-2045(26)00059-8.
Base: PUBMEDChallenges in the management of bone metastases: focus on differentiated thyroid cancer and neuroendocrine tumors.
Journal of the Endocrine Society. 2026 May; 10(May):bvag065. doi: 10.1210/jendso/bvag065. pii: bvag065.
Base: PUBMEDJoint Society Statement From the Society for Endocrinology (SfE), the British Thyroid Association (BTA) and the British Association of Endocrine and Thyroid Surgeons (BAETS) Regarding the Association of GLP-1 Agonists and Thyroid Cancer.
Clinical endocrinology. 2026 May; 104(May):507-509. doi: 10.1111/cen.70084. pii: .
Base: PUBMEDEfficacy and Safety of Cosibelimab for Advanced Cutaneous Squamous Cell Carcinoma: An Expert Consensus Panel.
Journal of drugs in dermatology : JDD. 2026 May; 25(May):413-420. doi: 10.36849/JDD.9954. pii: .
Base: PUBMEDThe clinical relevance of apocrine morphology in breast cancer depends on the estrogen receptor status.
NPJ breast cancer. 2026 Jun; doi: 10.1038/s41523-026-00981-6. pii: .
Base: PUBMEDDaraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer.
The New England journal of medicine. 2026 May; doi: 10.1056/NEJMoa2605555. pii: .
Base: PUBMEDCribriform/Intraductal carcinoma exhibits superior prognostic value over Gleason pattern 4 percentage and tertiary pattern 5 in Gleason pattern 4 prostate cancer.
World journal of urology. 2026 May; 44(May):doi: 10.1007/s00345-026-06450-w. pii: 355.
Base: PUBMEDAccelerating discovery of cancer causes for prevention in the era of rising early-onset cancers.
Cell. 2026 Apr; 189(Apr):2232-2253. doi: 10.1016/j.cell.2026.03.019. pii: S0092-8674(26)00286-2.
Base: PUBMEDWhole-body MRI for staging and follow-up of primary musculoskeletal tumours: a systematic review.
The British journal of radiology. 2026 Apr; 99(Apr):747-754. doi: 10.1093/bjr/tqag009. pii: .
Base: PUBMEDSurvival outcomes after neoadjuvant chemotherapy in hormone receptor-positive breast cancer patients with nodal metastases: A National Cancer Database analysis.
Surgery. 2026 May; 196(May):110236. doi: 10.1016/j.surg.2026.110236. pii: S0039-6060(26)00161-3.
Base: PUBMEDHighlights of the San Antonio Breast Cancer Symposium 2025 (Part 1).
Future oncology (London, England). 2026 May; 1-6. doi: 10.1080/14796694.2026.2668554. pii: .
Base: PUBMEDHighlights of the San Antonio breast cancer symposium 2025 (Part 2).
Future oncology (London, England). 2026 May; 1-5. doi: 10.1080/14796694.2026.2668557. pii: .
Base: PUBMEDSentinel Lymph Node Biopsy for Patients With cN1 HR+/HER2- Breast Cancer and Palpable Adenopathy: A Nonrandomized Clinical Trial.
JAMA surgery. 2026 May; doi: 10.1001/jamasurg.2026.1268. pii: e261268.
Base: PUBMEDLymph node surgery and CDK4/6 inhibitors in early breast cancer: a pooled analysis from five randomised trials.
The Lancet. Oncology. 2026 May; 27(May):604-613. doi: 10.1016/S1470-2045(26)00064-1. pii: S1470-2045(26)00064-1.
Base: PUBMEDComparing multifocal with unifocal breast cancer and the relationship with survival: national cohort study.
The British journal of surgery. 2026 May; 113(May):doi: 10.1093/bjs/znag033. pii: znag033.
Base: PUBMEDMetastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
Annals of oncology : official journal of the European Society for Medical Oncology. 2026 Apr; doi: 10.1016/j.annonc.2026.03.005. pii: S0923-7534(26)00108-0.
Base: PUBMEDEuropean guidelines for the diagnosis, treatment and follow-up of breast lesions with uncertain malignant potential (B3 lesions) developed jointly by EUSOMA, EUSOBI, ESP (BWG) and ESSO.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2024 Jan; 50(Jan):107292. doi: 10.1016/j.ejso.2023.107292. pii: S0748-7983(23)00930-7.
Base: PUBMEDBrazilian Society of Surgical Oncology: Guidelines and Consensus Statement for Palliative Surgery in Oncology.
Journal of surgical oncology. 2026 Mar; 133(Mar):421-432. doi: 10.1002/jso.70189. pii: .
Base: PUBMEDMultiple Myeloma, Version 5.2026, NCCN Clinical Practice Guidelines In Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN. 2026 Jan; 24(Jan):doi: 10.6004/jnccn.2026.0001. pii: e260001.
Base: PUBMEDAdult Cancer Pain, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN. 2025 Jul; 23(Jul):doi: 10.6004/jnccn.2025.0032. pii: e250032.
Base: PUBMEDNCCN Guidelines® Insights: Thyroid Carcinoma, Version 1.2025.
Journal of the National Comprehensive Cancer Network : JNCCN. 2025 Jul; 23(Jul):doi: 10.6004/jnccn.2025.0033. pii: e250033.
Base: PUBMEDCutaneous melanoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
Annals of oncology : official journal of the European Society for Medical Oncology. 2025 Jan; 36(Jan):10-30. doi: 10.1016/j.annonc.2024.11.006. pii: S0923-7534(24)04912-3.
Base: PUBMEDAGO Breast Commission recommendations for the surgical therapy of breast cancer: Working Group on Gynecologic Cancers (AGO) update 2025.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2025 Nov; 51(Nov):110445. doi: 10.1016/j.ejso.2025.110445. pii: S0748-7983(25)00873-X.
Base: PUBMEDCancer in pregnancy: FIGO Best practice advice and narrative review.
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. 2025 Oct; 171(Oct):131-151. doi: 10.1002/ijgo.70258. pii: .
Base: PUBMEDGastrointestinal stromal tumour (GIST): British Sarcoma Group clinical practice guidelines.
British journal of cancer. 2025 Jan; 132(Jan):1-10. doi: 10.1038/s41416-024-02672-0. pii: .
Base: PUBMEDBritish Gynaecological Cancer Society (BGCS) ovarian, tubal and primary peritoneal cancer guidelines: Recommendations for practice update 2024.
European journal of obstetrics, gynecology, and reproductive biology. 2024 Sep; 300(Sep):69-123. doi: 10.1016/j.ejogrb.2024.06.025. pii: S0301-2115(24)00314-2.
Base: PUBMEDASO Practice Guidelines Series: Multidisciplinary Management of Retroperitoneal Sarcomas.
Annals of surgical oncology. 2025 Jul; 32(Jul):5343-5355. doi: 10.1245/s10434-025-17284-y. pii: .
Base: PUBMEDOpioid conversion in adults with cancer: MASCC-ASCO-AAHPM-HPNA-NICSO guideline.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2025 Mar; 33(Mar):243. doi: 10.1007/s00520-025-09286-z. pii: .
Base: PUBMEDAASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma.
Hepatology (Baltimore, Md.). 2023 Dec; 78(Dec):1922-1965. doi: 10.1097/HEP.0000000000000466. pii: .
Base: PUBMEDLung Cancer Screening and Incidental Findings: A Research Agenda: An Official American Thoracic Society Research Statement.
American journal of respiratory and critical care medicine. 2025 Mar; 211(Mar):436-451. doi: 10.1164/rccm.202501-0011ST. pii: .
Base: PUBMEDRadiotherapy in cutaneous lymphomas: Recommendations from the EORTC cutaneous lymphoma tumour group.
European journal of cancer (Oxford, England : 1990). 2024 Nov; 212(Nov):115064. doi: 10.1016/j.ejca.2024.115064. pii: S0959-8049(24)01030-X.
Base: PUBMEDAcute Lymphoblastic Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN. 2024 Oct; 22(Oct):563-576. doi: 10.6004/jnccn.2024.0051. pii: .
Base: PUBMEDNCCN Guidelines® Insights: Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 3.2024.
Journal of the National Comprehensive Cancer Network : JNCCN. 2024 Oct; 22(Oct):512-519. doi: 10.6004/jnccn.2024.0052. pii: .
Base: PUBMEDChallenges and opportunities for early phase clinical trials of novel drug-radiotherapy combinations: recommendations from NRG Oncology, the American Society for Radiation Oncology (ASTRO), the American College of Radiology (ACR), the Sarah Cannon Research Institute, and the American College of Radiation Oncology (ACRO).
The Lancet. Oncology. 2024 Oct; 25(Oct):e489-e500. doi: 10.1016/S1470-2045(24)00264-X. pii: S1470-2045(24)00264-X.
Base: PUBMEDManagement of Locally Advanced Rectal Cancer: ASCO Guideline.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2024 Oct; 42(Oct):3355-3375. doi: 10.1200/JCO.24.01160. pii: .
Base: PUBMEDA joint ESTRO and AAPM guideline for development, clinical validation and reporting of artificial intelligence models in radiation therapy.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2024 Aug; 197(Aug):110345. doi: 10.1016/j.radonc.2024.110345. pii: S0167-8140(24)00615-7.
Base: PUBMEDEASL-ILCA Clinical Practice Guidelines on the management of intrahepatic cholangiocarcinoma.
Journal of hepatology. 2023 Jul; 79(Jul):181-208. doi: 10.1016/j.jhep.2023.03.010. pii: S0168-8278(23)00185-X.
Base: PUBMEDMultidisciplinary Treatment of Hepatocellular Carcinoma in 2023: Italian practice Treatment Guidelines of the Italian Association for the Study of the Liver (AISF), Italian Association of Medical Oncology (AIOM), Italian Association of Hepato-Bilio-Pancreatic Surgery (AICEP), Italian Association of Hospital Gastroenterologists (AIGO), Italian Association of Radiology and Clinical Oncology (AIRO), Italian Society of Pathological Anatomy and Diagnostic Cytology (SIAPeC-IAP), Italian Society of Surgery (SIC), Italian Society of Gastroenterology (SIGE), Italian Society of Medical and Interventional Radiology (SIRM), Italian Organ Transplant Society (SITO), and Association of Patients with Hepatitis and Liver Disease (EpaC) - Part I - Surgical treatments.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver. 2024 Feb; 56(Feb):223-234. doi: 10.1016/j.dld.2023.10.029. pii: S1590-8658(23)01019-8.
Base: PUBMEDCannabis and Cannabinoids in Adults With Cancer: ASCO Guideline.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2024 May; 42(May):1575-1593. doi: 10.1200/JCO.23.02596. pii: .
Base: PUBMEDNCCN Guidelines® Insights: Rectal Cancer, Version 3.2024.
Journal of the National Comprehensive Cancer Network : JNCCN. 2024 Aug; 22(Aug):366-375. doi: 10.6004/jnccn.2024.0041. pii: .
Base: PUBMEDEffects of exercise interventions on sarcopenia-related outcomes in cancer patients and survivors: an umbrella review of systematic reviews and meta-analyses.
Journal of cancer survivorship : research and practice. 2026 Jun; doi: 10.1007/s11764-026-02066-6. pii: .
Base: PUBMEDImpact of Surgical Delay on Breast Cancer Prognosis: Systematic Review and Meta-analysis.
Annals of surgical oncology. 2026 Jun; doi: 10.1245/s10434-026-20013-8. pii: .
Base: PUBMEDAdenoid cystic carcinoma of the breast: a case series of 26 patients.
Breast cancer research and treatment. 2026 Jun; 217(Jun):doi: 10.1007/s10549-026-07996-4. pii: 49.
Base: PUBMEDAssessing the impact of nutritional status at allogeneic stem cell transplantation on clinical outcomes.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2026 Jun; 34(Jun):doi: 10.1007/s00520-026-10874-w. pii: 645.
Base: PUBMEDThe clinical relevance of apocrine morphology in breast cancer depends on the estrogen receptor status.
NPJ breast cancer. 2026 Jun; doi: 10.1038/s41523-026-00981-6. pii: .
Base: PUBMEDESGO Consensus Statement on endometrial cancer prevention, risk reduction strategies, and management of women with Lynch syndrome.
European journal of cancer (Oxford, England : 1990). 2026 Jun; 240(Jun):116739. doi: 10.1016/j.ejca.2026.116739. pii: S0959-8049(26)00520-4.
Base: PUBMEDEndometrial cancer: A Society of Gynecologic Oncology evidence-based review and recommendations, part II.
Gynecologic oncology. 2026 Jun; 209(Jun):120-130. doi: 10.1016/j.ygyno.2026.05.006. pii: S0090-8258(26)01980-3.
Base: PUBMEDNeutrophil extracellular traps: A central player in liver diseases.
Hepatology communications. 2026 Jun; 10(Jun):doi: 10.1097/HC9.0000000000000970. pii: e0970.
Base: PUBMEDEndometrial cancer: A Society of Gynecologic Oncology evidence-based review and recommendations: Part I.
Gynecologic oncology. 2026 Jun; 209(Jun):15-25. doi: 10.1016/j.ygyno.2026.04.004. pii: S0090-8258(26)01944-X.
Base: PUBMEDDaraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer.
The New England journal of medicine. 2026 May; doi: 10.1056/NEJMoa2605555. pii: .
Base: PUBMED